<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01512043</url>
  </required_header>
  <id_info>
    <org_study_id>2009/2/0285</org_study_id>
    <nct_id>NCT01512043</nct_id>
  </id_info>
  <brief_title>Breathing Control in Patients With Chronic Obstructive Pulmonary Disease (COPD)</brief_title>
  <official_title>Breathing Control in Patients With Chronic Obstructive Pulmonary Disease (COPD) Intervention With Device-guided Breathing Control in COPD</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lovisenberg Diakonale Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Oslo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Norwegian Foundation for Health and Rehabilitation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Bergen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Lovisenberg Diakonale Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      There is a demand for explorative and comparative studies on various non-pharmaceutical
      efforts in treating and helping chronic obstructive pulmonary disease patients. This study
      has been developed in light of this need. The main purpose of the project is to test whether
      a device guided breathing control system can decreasing the feeling of breathlessness in
      patients with moderate stage and severe stage of COPD. In addition the study could shed light
      on whether a reduced feeling of breathlessness can lead to improved physical function, and
      less experience of other symptoms (I.e., depression, anxiety, sleeping difficulties, fatigue,
      pain) and provide a better quality of life for patients with COPD.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2011</start_date>
  <completion_date type="Actual">September 2013</completion_date>
  <primary_completion_date type="Actual">September 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Breathlessness</measure>
    <time_frame>4 months</time_frame>
    <description>Questionnaires</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Depression</measure>
    <time_frame>4 months</time_frame>
    <description>Questionnaires</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulmonary functional tests</measure>
    <time_frame>4 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety</measure>
    <time_frame>4 months</time_frame>
    <description>Questionnaires</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatigue</measure>
    <time_frame>4 months</time_frame>
    <description>Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleeping difficulties</measure>
    <time_frame>4 months</time_frame>
    <description>Questionnaires</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain</measure>
    <time_frame>4 months</time_frame>
    <description>Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6. Min walk test</measure>
    <time_frame>4 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arterial blood gas measures</measure>
    <time_frame>4 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>4 months</time_frame>
    <description>Questionnaire</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">150</enrollment>
  <condition>COPD</condition>
  <arm_group>
    <arm_group_label>1. Breathing control</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Description ...</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2. Listening to music</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Listening to music without guiding on breathing on the same device as breathing control twice a day for four weeks. Using the device to measure breathing movements.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3. Silence</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Using the device to measure breathing movement twice a day for four weeks. No instruction on breathing control and no music.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Breathing control</intervention_name>
    <description>Practice of device guided breathing control twice a day for four weeks.</description>
    <arm_group_label>1. Breathing control</arm_group_label>
    <arm_group_label>2. Listening to music</arm_group_label>
    <arm_group_label>3. Silence</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Dyspnoea symptoms in daily life

          -  Spirometry values showing a COPD moderate stage II (FEV1/FVC&lt;70%, FEV1&lt;80%) and
             severity grade at a severe stage III (FEV1/FVC&lt;70%, FEV1&lt;50% and FEV1 = 30% of a
             predicted)

          -  Be able to read, write and speak Norwegian

          -  Be at a stable phase of the disease

        Exclusion Criteria:

          -  Changes in pulmonary medication during the last 4 weeks

          -  Diagnosis of cancer

          -  Presently attending a pulmonary rehabilitation course or other similar COPD education
             courses (due to the fact that these courses often have instructions on breathing
             control), or having attended similar courses during the last six months

          -  Ongoing exacerbation

          -  Attending other competitive studies

          -  Diagnosis of neuromuscular disease

          -  Diagnosis of dementia

          -  Attending help from a pulmonary physiotherapist
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Astrid K Wahl, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Oslo</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Lovisenberg Diakonale Hospital</name>
      <address>
        <city>Oslo</city>
        <zip>0440</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 8, 2011</study_first_submitted>
  <study_first_submitted_qc>January 13, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 19, 2012</study_first_posted>
  <last_update_submitted>May 5, 2014</last_update_submitted>
  <last_update_submitted_qc>May 5, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 6, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Breathlessness</keyword>
  <keyword>Symptoms</keyword>
  <keyword>Quality of life</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

